ImmunityBio OverviewImmunityBio Total Revenue
Revenue analysis for IBRX.
Quarterly Revenue
$44.21M
↑ 167.64% YoY
As of Mar 2026
Annual Revenue (TTM)
$140.98M
↑ 353.74% YoY
Trailing 12 months ending Mar 2026
Average Revenue (Comparison Companies)
Total Revenue History
Total Revenue Comparison
Annual Revenue Growth Rate (%)
Annual Revenue Growth (Absolute)